23.3 C
New York
Wednesday, July 28, 2021

Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone

Must read

Wiv.io: Are NFTs The Future Of Wine?

Wiv.io: Are NFTs The Future Of Wine? As old as the world itself, wine has been an important cultural experience throughout human history - from...

US Bitcoin miner Stronghold files for $100M IPO to fund massive expansion

Sign In/Free Sign Up 0 Cryptocurrency23 minutes ago (Jul 28, 2021 01:20AM ET) US Bitcoin miner Stronghold files for $100M IPO to fund massive...

Dollar Up, Boosted by Plunge in Chinese Shares and Caution Ahead of Fed Decision

Forex28 minutes ago (Jul 28, 2021 01:15AM ET) (C) Reuters. By Gina Lee Investing.com - The dollar was up, but remained below its recent highs, on...

Nuggets News CEO under fire over alleged unpaid loans and investment funds

Sign In/Free Sign Up 0 Cryptocurrency43 minutes ago (Jul 28, 2021 01:00AM ET) Nuggets News CEO under fire over alleged unpaid loans and investment...
imageStock Markets38 minutes ago (Aug 24, 2020 04:05AM ET)

(C) Reuters. FILE PHOTO: Takeda Pharmaceutical’s logo is seen at its headquarters in Tokyo

TOKYO (Reuters) – Takeda Pharmaceutical Co said on Monday it has agreed to sell its Japanese consumer healthcare business to U.S. investment fund Blackstone Group (NYSE:BX).

Takeda Consumer Healthcare Company, which makes over-the-counter (OTC) drugs and health products, is valued at 242 billion yen ($2.29 billion) and the sale price will be determined after calculating its debt and other factors, Takeda said.

Japan’s largest pharmaceuticals company has been reducing its OTC assets worldwide as it seeks to refocus its business and reduce debt following its $59 billion acquisition of Shire.

Blackstone was among the final bidders for the OTC unit, Reuters reported in June, along with Bain Capital, CVC Capital Partners and Taisho Pharmaceutical Holdings Co Ltd.

Takeda said proceeds from the sale would boost its net profit by 105 billion yen. The transaction is expected close by March 31, subject to regulatory closing conditions, it said.

The deal follows Blackstone’s acquisition of Japan’s Ayumi Pharmaceutical Corp for $1 billion in March 2019.

Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

- Advertisement -

Latest article

Wiv.io: Are NFTs The Future Of Wine?

Wiv.io: Are NFTs The Future Of Wine? As old as the world itself, wine has been an important cultural experience throughout human history - from...

US Bitcoin miner Stronghold files for $100M IPO to fund massive expansion

Sign In/Free Sign Up 0 Cryptocurrency23 minutes ago (Jul 28, 2021 01:20AM ET) US Bitcoin miner Stronghold files for $100M IPO to fund massive...

Dollar Up, Boosted by Plunge in Chinese Shares and Caution Ahead of Fed Decision

Forex28 minutes ago (Jul 28, 2021 01:15AM ET) (C) Reuters. By Gina Lee Investing.com - The dollar was up, but remained below its recent highs, on...

Nuggets News CEO under fire over alleged unpaid loans and investment funds

Sign In/Free Sign Up 0 Cryptocurrency43 minutes ago (Jul 28, 2021 01:00AM ET) Nuggets News CEO under fire over alleged unpaid loans and investment...

Why Tuesday’s Loss Was Bullish, And Why It Still Doesn’t Matter

SPX Index Daily Chart Tuesday was a mixed session for the S&P 500. The index opened with losses and the one-way selling knocked stocks down...